Diagnosing a genetic disease in a donor-conceived child: case report and discussion of the ethical, legal, and practical issues.

Bibliographic Details
Title: Diagnosing a genetic disease in a donor-conceived child: case report and discussion of the ethical, legal, and practical issues.
Authors: Lemaire, Mathieu1,2 mathieu.lemaire@sickkids.ca, Noone, Damien3, Waldman, Larissa4,5, Liu, Kimberly E.6, Mulder, Jaap7,8, Cohen, Sara R.9,10, Greenberg, Rebecca A.2, Chad, Lauren2,11,12 lauren.chad@sickkids.ca
Source: Pediatric Nephrology. Mar2025, Vol. 40 Issue 3, p859-864. 6p.
Subject Terms: *GENETIC disorder diagnosis, *GENETIC testing laws, *HEALTH services accessibility, *PROFESSIONAL practice, *PEDIATRICIANS, *OCCUPATIONAL roles, *GENOMICS, *GENEALOGY, *GENETIC privacy, *OVUM donation, *FERTILIZATION in vitro, *SPERM donation, *X-linked genetic disorders, *COMMUNICATION, *FERTILITY clinics, *GENETIC techniques, *GENETIC mutation, *STAKEHOLDER analysis, *GENETIC testing, *PSYCHOSOCIAL factors, *INTERGENERATIONAL relations
Geographic Terms: CANADA
Abstract: We describe the unexpected challenges pediatricians may experience when children conceived with assisted reproduction are diagnosed with a rare genetic condition. A local case series triggered a dialogue between many stakeholders with varied expertise. Indeed, diagnosing a genetic disease in a child conceived by embryo, egg, or sperm donation is becoming more common now that genetic testing and in vitro fertilization (IVF) are readily accessible. However, how and whether to share that information with other stakeholders in the gamete donation process has not been fully explored, and the clinical responsibilities of the treating clinician remain ill-defined. This work centers on a patient with a confirmed diagnosis of X-linked nephrogenic diabetes insipidus. Ultimately, we found the same AVPR2 mutation in two children from two families conceived by egg donation. It led to multigenerational cascade diagnoses in the family of the shared, anonymous egg donor. First, we review current genetic testing practices in gamete donation and third-party reproduction. Then, we provide an overview of relevant genomic, ethical, legal, and psychosocial considerations for sharing relevant genomic information. Finally, and to maximize the best interests of genetic relatives, we discuss how a pediatrician can play a role in the early disclosure of relevant clinical information to all stakeholders in the gamete donation process, starting with the fertility clinic. While these clinical cases are cast in a Canadian context, we submit that its important lessons generally apply to medical systems of nearly all developed countries, broadly defined. [ABSTRACT FROM AUTHOR]
Copyright of Pediatric Nephrology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
More Details
ISSN:0931041X
DOI:10.1007/s00467-024-06556-6
Published in:Pediatric Nephrology
Language:English